Trial · NCT02195700
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Centrally Read Abnormal Involuntary Movement Scale (AIMS) Score From Baseline to Week 12 Using Mixed Model Repeated Measures (MMRM) Analysis | SD-809 | -3.0 | Standard Error 0.45 | units on a scale | |
| Change in Centrally Read Abnormal Involuntary Movement Scale (AIMS) Score From Baseline to Week 12 Using Mixed Model Repeated Measures (MMRM) Analysis | Placebo | -1.6 | Standard Error 0.46 | units on a scale | |
| Percentage of Patients Who Are a Treatment Success at Week 12 as Assessed by the Clinical Global Impression of Change (CGIC) | SD-809 | 48.2 | percentage of participants | ||
| Percentage of Patients Who Are a Treatment Success at Week 12 as Assessed by the Clinical Global Impression of Change (CGIC) | Placebo | 40.4 | percentage of participants | ||
| Percentage of Patients Who Are a Treatment Success at Week 12 as Assessed by the Patient Global Impression of Change (PGIC) | SD-809 | 42.9 | percentage of participants | ||
| Percentage of Patients Who Are a Treatment Success at Week 12 as Assessed by the Patient Global Impression of Change (PGIC) | Placebo | 29.8 | percentage of participants | ||
| Change From Baseline to Week 12 in the Modified Craniocervical Dystonia Questionnaire (CDQ-24) | SD-809 | -11.1 | Standard Error 2.14 | units on a scale | |
| Change From Baseline to Week 12 in the Modified Craniocervical Dystonia Questionnaire (CDQ-24) | Placebo | -8.3 | Standard Error 2.31 | units on a scale | |
| Participants With Adverse Events for the Overall Treatment Period | SD-809 | Overall Treatment Period: any AE | 41 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | Placebo | Overall Treatment Period: any AE | 36 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | SD-809 | Overall Treatment Period: SAE | 3 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | Placebo | Overall Treatment Period: SAE | 5 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | SD-809 | Overall Treatment Period: Severe AE | 3 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | Placebo | Overall Treatment Period: Severe AE | 3 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | SD-809 | Overall Treatment Period: treatment-related AE | 28 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | Placebo | Overall Treatment Period: treatment-related AE | 21 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | SD-809 | Overall Treatment Period: Deaths | 0 | Participants | |
| Participants With Adverse Events for the Overall Treatment Period | Placebo | Overall Treatment Period: Deaths | 0 | Participants | |
| Percentage Change in Centrally Read Abnormal Involuntary Movement Scale (AIMS) Score From Baseline to Week 12 Using MMRM Analysis | SD-809 | -26.7 | Standard Error 6.06 | percentage change | |
| Percentage Change in Centrally Read Abnormal Involuntary Movement Scale (AIMS) Score From Baseline to Week 12 Using MMRM Analysis | Placebo | -15.5 | Standard Error 6.26 | percentage change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02195700/results